PMID: 7011222Mar 1, 1981Paper

A randomized comparison of cefoxitin with or without amikacin and clindamycin plus amikacin in surgical sepsis

Annals of Surgery
F P TallyT F O'Donnell

Abstract

The efficacy of cefoxitin, either alone or in combination (+/-) with an aminoglycoside was compared with clindamycin plus (+), an aminoglycoside for the treatment of mixed aerobic-anaerobic surgical infections, in a prospective randomized single blinded study. One hundred patients were entered into the study; 37 patients were assessable for clinical outcome in both groups, while toxicity could be assessed in 46 patients in the cefoxitin group and 47 in the clindamycin group. The groups were evenly matched considering age, sex, and type of infection. Favorable clinical responses were achieved in 34 of 37 patients treated with cefoxitin +/- amikacin, and 29 of 37 patients treated with clindamycin + amikacin; there was no statistical difference between the groups (p greater than 0.1). The incidences of toxicity were the same. Our study has demonstrated that cefoxitin with or without an aminoglycoside is as effective as clindamycin plus an aminoglycoside in the therapy of serious mixed infections in surgical patients.

References

Dec 14, 1979·JAMA : the Journal of the American Medical Association·J G BartlettB Lowe
Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
May 1, 1978·Obstetrical & Gynecological Survey·H ThadepalliJ G Bartlett
Sep 1, 1978·Antimicrobial Agents and Chemotherapy·F P TallyS L Gorbach
Jan 1, 1979·The Journal of Antimicrobial Chemotherapy·F P TallyS L Gorbach
Mar 1, 1977·The Journal of Infectious Diseases·J G BartlettS L Gorbach
Oct 1, 1976·Antimicrobial Agents and Chemotherapy·V L Sutter, S M Finegold
Dec 11, 1976·British Medical Journal·S J Eykyn, I Phillips
Sep 1, 1975·Annals of Internal Medicine·S M FinegoldF P Tally
Feb 1, 1972·Antimicrobial Agents and Chemotherapy·W J MartinJ A Washington
Aug 1, 1973·Surgery, Gynecology & Obstetrics·H ThadepalliL Nyhus

❮ Previous
Next ❯

Citations

Nov 1, 1986·Journal of General Internal Medicine·M C WeinsteinH C Hutchings
May 8, 2004·International Journal of Pharmaceutics·Pao-Chu WuYaw-Bin Huang
Jul 1, 1996·American Journal of Surgery·R L Nichols
Aug 28, 1982·Lancet·J G Bartlett
Apr 18, 2000·Critical Care Clinics·D Simon, G Trenholme
Oct 25, 1984·The New England Journal of Medicine·R L NicholsJ Mills
Aug 1, 1990·Annals of Surgery·P S BarieJ P Waymack
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·G J CuchuralJ W Mayhew
May 1, 1984·Antimicrobial Agents and Chemotherapy·W L George
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·J L Ho, M Barza
Jul 1, 1994·Intensive Care Medicine·S L Gorbach
Oct 1, 1987·Current Problems in Pediatrics·I Brook
Jul 15, 1985·The American Journal of Medicine·S H Dougherty
Sep 1, 1984·American Journal of Surgery·S H Dougherty
Jul 1, 1984·Current Problems in Surgery·T HauM I Aeder
Aug 1, 1984·Annals of Emergency Medicine·T G MajernickS Brotman
Aug 1, 1985·Burns, Including Thermal Injury·J F HansbroughJ A Boswick
Mar 1, 1994·American Journal of Surgery·D M MosdellD E Fry
Jun 7, 1985·The American Journal of Medicine·F P Tally, S L Gorbach
Feb 1, 1993·American Journal of Surgery·J T DiPiro, N S Fortson
Jan 30, 2007·Expert Opinion on Pharmacotherapy·Ioannis P KioumisDavid P Nicolau
Jan 1, 1984·Scandinavian Journal of Infectious Diseases. Supplementum
Jan 1, 1983·American Journal of Surgery·S SainiL E Curtis
Apr 1, 1988·Critical Care Clinics·M C Robson
Apr 23, 2005·The Cochrane Database of Systematic Reviews·P F WongD J Leaper
Apr 24, 2003·Pediatrics International : Official Journal of the Japan Pediatric Society·Itzhak Brook
Feb 25, 1988·The New England Journal of Medicine·G R Donowitz, G L Mandell
Jan 1, 2014·Geomicrobiology Journal·Jennifer J Marshall HathawayDiana E Northup
Oct 1, 1990·Hospital Practice·I Brook
May 1, 1987·Drug Intelligence & Clinical Pharmacy·L Danziger, E Hassan
Mar 15, 1986·Hospital Practice·A E Glatt
Dec 1, 1981·Hospital Practice·F P Tally
Jul 1, 1982·Postgraduate Medicine·R Gleckman, O H DeTorres

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.